Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01071655
What this trial is testing

Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 195
Testing effectiveness (Phase 2)Looking for participantsNCT05751343
What this trial is testing

Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 55
Not applicableLooking for participantsNCT07241663
What this trial is testing

Surgery for Locally Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 150
Not applicableUnknownNCT04831632
What this trial is testing

Diagnostic Performance Assessment of Qualitative Ifobt and Quantitative Ifobt for Advanced Neoplastic

Who this might be right for
Colorectal Neoplasms
CECILIA CURVALE 630
Testing effectiveness (Phase 2)UnknownNCT05620498
What this trial is testing

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.

Who this might be right for
Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT00503321
What this trial is testing

Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma

Who this might be right for
Gastric Cancer
Eastern Network of Cancer Immunological Therapy, Japan 13
Large-scale testing (Phase 3)Ended earlyNCT01437514
What this trial is testing

Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer

Who this might be right for
Rectal Neoplasms
West China Hospital 410
Testing effectiveness (Phase 2)Study completedNCT01444521
What this trial is testing

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)WithdrawnNCT03991104
What this trial is testing

SOX-based CRT for Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Zhejiang Provincial People's Hospital
Testing effectiveness (Phase 2)Study completedNCT00045747
What this trial is testing

UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT01822756
What this trial is testing

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsPancreatic Cancer
Incyte Corporation 42
Testing effectiveness (Phase 2)Looking for participantsNCT06452602
What this trial is testing

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableUnknownNCT05349045
What this trial is testing

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
The First Affiliated Hospital of Zhengzhou University 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05945901
What this trial is testing

A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 669
Testing effectiveness (Phase 2)Study completedNCT00508001
What this trial is testing

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Genzyme, a Sanofi Company 67
Early research (Phase 1)Study completedNCT01395667
What this trial is testing

Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX

Who this might be right for
Rectal Cancer
National Taiwan University Hospital 15
Early research (Phase 1)UnknownNCT04032392
What this trial is testing

Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01093222
What this trial is testing

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct AdenocarcinomaGallbladder AdenocarcinomaGallbladder Adenocarcinoma With Squamous Metaplasia+6 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01253837
What this trial is testing

L19TNFα in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsColorectal Cancer
Philogen S.p.A. 34
Not applicableEnded earlyNCT03402477
What this trial is testing

"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Helse Stavanger HF 86
Next Page